Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Tandem Diabetes Care (TNDM) Net Margin (2016 - 2025)

Tandem Diabetes Care's Net Margin history spans 13 years, with the latest figure at 0.18% for Q4 2025.

  • For Q4 2025, Net Margin fell 45.0% year-over-year to 0.18%; the TTM value through Dec 2025 reached 20.17%, down 996.0%, while the annual FY2025 figure was 20.17%, 996.0% down from the prior year.
  • Net Margin reached 0.18% in Q4 2025 per TNDM's latest filing, up from 8.49% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 5.13% in Q4 2021 to a low of 73.13% in Q1 2023.
  • Average Net Margin over 5 years is 14.79%, with a median of 9.0% recorded in 2024.
  • Peak YoY movement for Net Margin: crashed -6479bps in 2023, then soared 5084bps in 2024.
  • A 5-year view of Net Margin shows it stood at 5.13% in 2021, then plummeted by -241bps to 7.21% in 2022, then plummeted by -111bps to 15.23% in 2023, then surged by 102bps to 0.27% in 2024, then tumbled by -164bps to 0.18% in 2025.
  • Per Business Quant, the three most recent readings for TNDM's Net Margin are 0.18% (Q4 2025), 8.49% (Q3 2025), and 21.77% (Q2 2025).